Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4354370 | 0.76 | RAB9A (0.37) | RAB9AMAPT | |
| SCHEMBL4348979 | 0.73 | GABRA1 (0.35) | RAB9AMAPT | |
| SCHEMBL1306681 | 0.73 | TSHR (0.37) | — | |
| SCHEMBL1305649 | 0.73 | RELA (0.36) | RAB9A | |
| SCHEMBL1305826 | 0.73 | NR1H2 (0.31) | — | |
| SCHEMBL1306794 | 0.73 | PYCR1 (0.34) | MAPT | |
| SCHEMBL1306585 | 0.73 | NR1H2 (0.31) | — | |
| SCHEMBL1308149 | 0.73 | ESR1 (0.41) | MAPT | |
| SCHEMBL1305375 | 0.73 | ALDH1A1 (0.38) | — | |
| SCHEMBL15302545 | 0.73 | MEN1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090054649-A1 | Bridged Organosilane and Production Method Thereof | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20090054649-A1 | Bridged Organosilane and Production Method Thereof | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2009-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054649-A1 | Bridged Organosilane and Production Method Thereof | C5, CCNE1, QSOX1 | RAB9A 1423/4885MAPT 3900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.